About BRXCX
MFS Blended Research International Equity Fund Class C is an international equity mutual fund designed to provide investors with long-term capital appreciation by investing primarily in foreign companies. The fund employs a distinctive strategy that integrates both fundamental and quantitative research techniques, seeking to identify high-quality companies outside the United States that are trading at attractive valuations and possess catalysts for growth. It generally allocates at least 80% of its assets to equity securities, with a focus on large-cap companies across a diverse array of sectors, including technology, healthcare, financial services, consumer defensive, industrials, and energy. Key holdings often feature globally recognized firms such as Taiwan Semiconductor Manufacturing, Roche Holding, and ASML Holding. The fund is benchmarked against the MSCI All Country World (ex-US) Index, reflecting its aim to capture opportunities in both developed and emerging international markets. With a minimum initial investment of $1,000, Class C shares are structured for investors seeking global diversification without an initial sales charge, though a contingent deferred sales charge may apply if shares are redeemed within a year. The fund plays a significant role for investors aiming to broaden their international equity exposure while leveraging MFS’s combined research methodology.
Fund Family MFS
Category Foreign Large Blend
Performance Rating High
Risk Rating Below Average
Stock Exchange NASDAQ
Ticker Symbol BRXCX
Share Class C
Index MSCI AC World ex USA NR USD
BRXCX had a total return of 30.70% in the past year, including dividends.
Since the fund's inception, the average annual return has been 9.06%.
